Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Entrada Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +2 vs. Q4 2021
- Shares held
- 25.9M
- +506.3K (+2.0%) vs. Q4 2021
- Total value
- $242.8M
- −$191.0M (−44.0%) vs. Q4 2021
- New holders
- 8
- 14 more added
- Sold out
- 6
- 12 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 413 | $4.00K | 0.00% | −1,980−82.7% | Reduced |
| Royal Bank of Canada | 646 | $6.00K | 0.00% | −1,217−65.3% | Reduced |
| Ameritas Investment Partners, Inc. | 708 | $7.00K | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 700 | $7.00K | 0.00% | +700 | New |
| Legal & General Group Plc | 848 | $8.00K | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 1,060 | $10.0K | 0.01% | +829+358.9% | Added |
| UBS Group AG | 1,447 | $13.0K | 0.00% | −1,367−48.6% | Reduced |
| Amalgamated Bank | 1,350 | $13.0K | 0.00% | +1,350 | New |
| Amalgamated Financial Corp. | 1,350 | $13.0K | 0.00% | +1,350 | New |
| Barclays PLC | 1,709 | $16.0K | 0.00% | +1,709 | New |
| STRS Ohio | 2,100 | $19.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,285 | $21.0K | 0.00% | −3,035−57.0% | Reduced |
| Tower Research Capital LLC (TRC) | 2,485 | $23.0K | 0.00% | +7+0.3% | Added |
| California State Teachers Retirement System | 4,446 | $42.0K | 0.00% | −570−11.4% | Reduced |
| JPMorgan Chase & Co | 4,934 | $46.0K | 0.00% | +1,440+41.2% | Added |
| New York State Common Retirement Fund | 4,880 | $46.0K | 0.00% | +4,880 | New |
| Deutsche Bank AG | 4,959 | $47.0K | 0.00% | −608−10.9% | Reduced |
| American International Group, Inc. | 5,223 | $49.0K | 0.00% | +356+7.3% | Added |
| Morgan Stanley | 8,361 | $78.0K | 0.00% | +4,199+100.9% | Added |
| Renaissance Technologies LLC | 11,800 | $111.0K | 0.00% | −1,773−13.1% | Reduced |
| Nuveen Asset Management, LLC | 13,872 | $130.0K | 0.00% | 00.0% | Unchanged |
| Ghisallo Capital Management LLC | 15,000 | $141.0K | 0.02% | 00.0% | Unchanged |
| Bank of America Corp | 20,871 | $196.0K | 0.00% | −1,971−8.6% | Reduced |
| Bank of New York Mellon Corp | 21,933 | $206.0K | 0.00% | +8,276+60.6% | Added |
| Manufacturers Life Insurance Company, The | 41,175 | $393.1K | 0.00% | +41,175 | New |
| Walleye Capital LLC | 44,652 | $419.0K | 0.01% | +44,652 | New |
| TD Asset Management Inc | 57,675 | $542.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 64,399 | $604.0K | 0.00% | −44,395−40.8% | Reduced |
| Charles Schwab Investment Management Inc | 68,704 | $646.0K | 0.00% | +4,685+7.3% | Added |
| Northern Trust Corp | 90,258 | $847.0K | 0.00% | +10,775+13.6% | Added |
| Moore Capital Management, LP | 105,000 | $986.0K | 0.03% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 106,000 | $995.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 151,194 | $1.42M | 0.00% | +70,075+86.4% | Added |
| Nan Fung Group Holdings Ltd | 173,582 | $1.63M | 0.77% | +173,582 | New |
| Geode Capital Management, LLC | 177,733 | $1.67M | 0.00% | +15,546+9.6% | Added |
| Vanguard Group Inc | 430,404 | $4.04M | 0.00% | +5,452+1.3% | Added |
| Goldman Sachs Group Inc | 445,455 | $4.18M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 445,520 | $4.18M | 0.00% | +1,094+0.2% | Added |
| 72 Investment Holdings, LLC | 509,023 | $4.78M | 5.23% | −10.0% | Reduced |
| TCG Crossover Management, LLC | 663,694 | $6.13M | 2.46% | 00.0% | Unchanged |
| StepStone Group LP | 761,277 | $7.15M | 0.53% | 00.0% | Unchanged |
| FMR LLC | 876,794 | $8.23M | 0.00% | +590,994+206.8% | Added |
| Redmile Group, LLC | 1,954,419 | $18.4M | 0.57% | −10.0% | Reduced |
| Price T Rowe Associates Inc | 2,494,714 | $23.4M | 0.00% | +474,077+23.5% | Added |
| Wellington Management Group LLP | 2,543,102 | $23.8M | 0.00% | −570,904−18.3% | Reduced |
| 5AM Venture Management, LLC | 4,408,379 | $41.4M | 9.04% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,425,784 | $41.6M | 14.20% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,704,419 | $44.2M | 0.25% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −255,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −46,504−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,090−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −215−100.0% | Sold out |